ACCESS Newswire

NovaSight Ltd.

Share
NovaSight CureSight (TM) Wins 2023 MedTech Breakthrough Award

CureSight™ Amblyopia treatment device named "Best New Technology Solution for Ophthalmology" for its innovation, impact, and market potential

LOD, ISRAEL / ACCESSWIRE / May 4, 2023 / NovaSight, a pediatric-focused eyecare MedTech company, announced today that its CureSight binocular digital treatment system for amblyopia (lazy eye) has been named "Best New Technology Solution for Ophthalmology" in the 7th annual MedTech Breakthrough Awards program. The award program is conducted by MedTech Breakthrough, an independent market intelligence organization that recognizes the top companies, technologies, and products in the global health and medical technology market.

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.
CureSight wins Medtech Breakthrough award 2023



NovaSight provides pediatric patients with eye-tracking based digital vision care solutions by focusing on three major verticals: treatment, diagnostics, and prevention of visual health impairments.

CureSight is an FDA-cleared and CE marked eye-tracking based amblyopia treatment system, designed to replace the traditional eye patching. The treatment is carried out while the patient watches his favorite streamed content from the comfort of his home. By tracking the gaze position of the dominant eye in real-time, the CureSight system blurs its center of vision, while keeping the rest of the image sharp - and providing the amblyopic eye with a normal, high contrast image. This stimulates the brain to complete the blurred image from the amblyopic eye, improving its acuity and developing stereoacuity as the eyes learn to work together.

"Amblyopia, or what's known as 'lazy-eye' affects three percent of the population and puts the patients at risk for eventual vision loss. The gold standard treatment for lazy eye has so far consisted of placing a patch over the strong eye - an old-fashioned solution which suffers from very low compliance," said James Johnson, managing director, MedTech Breakthrough. "With the breakthrough of CureSight's binocular treatment from NovaSight, children develop stereoscopic vision, which is difficult to achieve with the monocular nature of the traditional patching treatment. This breakthrough technology helps to shift treatment into the digital age and we are thrilled to congratulate the NovaSight team for taking home a well-deserved 2023 MedTech Breakthrough Award."

The mission of the MedTech Breakthrough Awards is to honor excellence and recognize the innovation, hard work and success in a range of health and medical technology categories, including Telehealth, Clinical Administration, Patient Engagement, Electronic Health Records (EHR), Virtual Care, Medical Devices, Medical Data and many more. This year's program attracted more than 4,000 nominations from over 17 different countries throughout the world.

"We are proud to be named 'Best New Technology Solution for Ophthalmology' acknowledging our mission to prevent vision impairments among pediatric patients by developing solutions that are specifically designed for the unique needs and attention span of children" said Ran Yam, NovaSight co-founder and CEO. "In a recent pivotal trial which was the basis for our FDA approval, we compared the improvement in visual outcomes (visual acuity and stereoacuity) achieved by CureSight versus the traditional eye patch. This is the first ever pivotal trial where a digital device was shown to be non-inferior to eye patching for amblyopia treatment in children. We will continue to strive to change the lives of millions of children by introducing eye tracking based vision care solutions."

Additionally, the CureSight system is connected to a dedicated cloud platform which allows the physician to monitor treatment progress and compliance remotely. The eye care provider receives a comprehensive patient vision summary, and progress reports and real-time monitoring of the child's treatment are easily accessible.

CureSight was officially launched in the US and Italy earlier this year with exceptional early adoption by the pediatric ophthalmology community and their patients. Equipped with 3 unique CPT codes in the US assigned by the American Medical Association (AMA) last year, NovaSight is pursuing broad coverage with the aim of making CureSight easily accessible to patients whose future vision and eye health depend on the treatment that they receive in their early years.

####

About NovaSight
NovaSight is an Israeli MedTech company that focuses on bringing pediatric vision care into the digital age. Founded in 2016, NovaSight has experienced rapid growth by delivering complete end-to-end eye-tracking-based solutions for accurate assessment and treatment of early vision disorders.

NovaSight offers two flagship products, both ideally positioned for remote diagnostics and home treatment: The CureSight™ system is an eye tracking-based treatment for lazy eye designed to replace traditional eye patching. The EyeSwift®PRO system is a comprehensive vision assessment device that accurately and objectively screens for multiple vision impairments within seconds. Additional pipeline products include the TrackSight™ digital solution for myopia (short-sightedness) control, targeted to provide an affordable and accessible solution to help in combating the myopia global epidemic, which is growing at an alarming rate.

NovaSight's management and advisory board is composed of accomplished executives, physicians, researchers, and key opinion leaders in the field of vision care.

About MedTech Breakthrough
Part of Tech Breakthrough, a leading market intelligence and recognition platform for global technology innovation and leadership, the MedTech Breakthrough Awards program is devoted to honoring excellence and innovation in medical & health technology companies, products, services and people. The MedTech Breakthrough Awards provide a platform for public recognition around the achievements of breakthrough healthcare and medical companies and products in categories that include Patient Experience & Engagement, Health & Fitness, Medical Devices, Clinical Administration, Connected Healthcare, Medical Data, Healthcare Cybersecurity and more. For more information visit MedTechBreakthrough.com.

Contact Information

Jenny Goldman
Marketing manager
jenny@nova-sight.com
+972 50 9123235

SOURCE: NovaSight Ltd.

To view this piece of content from stats.newswire.com, please give your consent at the top of this page.

View source version on accesswire.com:
https://www.accesswire.com/752936/NovaSight-CureSight-TM-Wins-2023-MedTech-Breakthrough-Award

To view this piece of content from www.accesswire.com, please give your consent at the top of this page.

About ACCESS Newswire

DK

Subscribe to releases from ACCESS Newswire

Subscribe to all the latest releases from ACCESS Newswire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from ACCESS Newswire

Camino Announces High-Grade Channel Results of 7 Meters @ 4.3% Copper, 25.5 ppm Silver and 18 meters @ 1.57 % Copper and 11.35 ppm Silver at Los Chapitos in Peru17.6.2025 12:00:00 CEST | Press release

VANCOUVER, BC / ACCESS Newswire / June 17, 2025 / Camino Minerals Corporation (TSXV:COR)(OTC PINK:CAMZF) ("Camino" or the "Company") is pleased to announce high‐grade copper channel results from the Katty prospect located in the Diva Trend, one of several prospective targets at the Company's Los Chapitos Copper Project ("Los Chapitos" or the "Project") in Peru. A total of 12 excavated channels were completed at the prospect and all channels contained significant high-grade intercepts of copper with associated silver (Table 1). Los Chapitos is Camino's second copper project with partner Nittetsu Mining Co, Ltd. ("Nittetsu"), which can earn a 35% interest in Los Chapitos once it completes a total investment of CDN$10 Million (see news release dated June 14, 2023). Rio Tinto, a major copper producer, recently staked claims adjacent to Los Chapitos (see news release dated May 17, 2024). Camino is also advancing its mine development project, the Puquios Copper Project, with Nittetsu Mining

The 12th GLA Global Logistics Conference: A New Chapter in International Logistics Cooperation17.6.2025 05:50:00 CEST | Press release

DUBAI, AE / ACCESS Newswire / June 16, 2025 / From May 15 to 18, 2025, the 12th GLA Global Logistics Conference was held at the Grand Hyatt Dubai, shaping the future of the international logistics landscape. Organized by the Global Logistics Enterprises Federation (GLEF) and the GLA Global Logistics Alliance, the conference gathered nearly 2,000 professionals, including logistics experts, senior executives and government officials from over 130 countries and regions. This year's edition reinforced GLA's position as a central hub for strategic networking, innovation and global trade cooperation. Group Photo of the 12th GLA Global Logistics Conference Under the theme "Peaceful Prosperity · Digital Innovation · Trustworthy Cooperation," the conference reflected the logistics sector's collective ambition to respond to today's challenges, ranging from geopolitical disruptions and supply chain volatility to technological advancement and environmental demands. The Opening Ceremony of the 12th

Corsair Signs Strategic Partnership with Kera Energy for Global Distribution of Pyrolysis Oil16.6.2025 09:10:00 CEST | Press release

New partnership expands global access to Corsair's recycled plastic oil across Europe, Asia, and the Americas. AMSTERDAM, NETHERLANDS / ACCESS Newswire / June 16, 2025 / Plastic waste recycling company Corsair Group International Holding BV (CORSAIR) is proud to announce a new strategic partnership with KERA Energy AG, a Swiss-based leader in sustainable industrial value chains. Under the agreement, CORSAIR will supply advanced pyrolysis oil to KERA Energy, which will distribute the Plastic Pyrolysis Oil (PPO) across key markets in Europe, Asia, and the Americas. This collaboration marks another important step in CORSAIR's mission to scale up sustainable advanced recycling of plastic waste. The agreement with KERA Energy signals growing international demand for CORSAIR's high-quality pyrolysis oil derived from everyday household plastic waste. "We are very pleased to partner with KERA Energy, a company that shares our vision of a cleaner, circular economy," said Jussi Veikko Saloranta,

GA-ASI Announces New PELE Small UAS for International Customers16.6.2025 06:00:00 CEST | Press release

Small, Uncrewed Launched Effect Delivers Multi-Mission Capability SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI), the world leader in unmanned aircraft from the iconic Predator® to the YFQ-42A Collaborative Combat Aircraft, has unveiled a new small uncrewed launched effect with widespread multi-mission capabilities for the global aerospace and defense market. Inspired by Pele, the Hawaiian goddess of powerful natural forces in the Pacific, the Precision Exportable Launched Effect - PELE - is a small, attrition-tolerant, propeller-driven unmanned aircraft designed to extend the sensing and other capabilities of a mothership aircraft and its user service. PELE is a semi-autonomous unmanned aircraft system (UAS) with an 11-foot wingspan and 16-horsepower engine that extends user reach within challenging environments with potent effects. PELE also could be launched from the ground. The new PELE is optimized for use on the MQ-9B SkyGuar

GA-ASI Adds Saab Airborne Early Warning Capability to MQ-9B16.6.2025 06:00:00 CEST | Press release

New Capability Will Transform Airborne Early Warning Access and Affordability for MQ-9B Customers SAN DIEGO, CA / ACCESS Newswire / June 16, 2025 / General Atomics Aeronautical Systems, Inc. (GA-ASI) is partnering with Saab to develop Airborne Early Warning and Control (AEW&C) capability for its line of MQ-9B Remotely Piloted Aircraft, which includes the SkyGuardian® and SeaGuardian® models, the United Kingdom's Protector, and the new MQ-9B STOL (Short Takeoff and Landing) model currently in development. GA-ASI plans to fly AEW on MQ-9B in 2026. "High and low-tech air threats both pose major challenges to global air forces," said GA-ASI President David R. Alexander. "We're developing an affordable AEW solution in cooperation with Saab, the leading provider of AEW&C systems, that will transform our customers' operations against both sophisticated cruise missiles and simple but dangerous drone swarms. We're also making AEW capability possible in areas it doesn't exist today, such as from

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye